Clinical trial
Impact of Starting Dose of Vasopressor on Hemodynamic Response in Shock
NCT06481839 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Starting Dose of Vasopressor on Hemodynamic Response in Shock
- Lead sponsor
- University of Illinois at Chicago
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 24, 2024
- Completion date
- July 24, 2028
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.